|
HS Code |
518302 |
| Name | Glycyrrhizae Radix Et Rhizoma Veterinary Grade API |
| Plant Source | Glycyrrhiza uralensis (Licorice root) |
| Form | Powder |
| Pharmaceutical Applications | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Cas Number | 90045-18-6 |
| Main Active Compounds | Glycyrrhizin, Flavonoids, Polysaccharides |
| Usage | Veterinary pharmaceuticals |
| Appearance | Yellow-brown powder |
| Solubility | Water soluble |
| Storage Conditions | Store in a cool, dry, and dark place |
| Purity | ≥98% (by HPLC) |
| Shelf Life | 2 years |
| Mechanism Of Action | Anti-inflammatory, immunomodulatory, hepatoprotective |
| Extraction Method | Water/alcohol extraction from root and rhizome |
| Regulatory Status | Veterinary grade, complies with relevant pharmacopeias |
As an accredited Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Glycyrrhizae Radix Et Rhizoma Veterinary Grade API, 25kg fiber drum with inner double-layer polyethylene bag, for pharmaceutical formulations. |
| Shipping | The Glycyrrhizae Radix Et Rhizoma Veterinary Grade API is securely packed in sealed, moisture-proof containers or fiber drums. Each shipment is clearly labeled and protected against contamination and damage. The API is shipped via temperature-controlled transport to ensure quality, complying with international regulations for pharmaceutical ingredients. |
| Storage | Glycyrrhizae Radix Et Rhizoma Veterinary Grade API should be stored in a cool, dry, and well-ventilated area away from direct sunlight and sources of heat or moisture. Keep the container tightly closed and store at room temperature. Ensure it is protected from contamination and incompatible materials; follow all relevant local regulations and guidelines for pharmaceutical storage. |
|
Purity 99%: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with 99% purity is used in veterinary anti-inflammatory treatments, where high purity ensures consistent therapeutic efficacy. Particle Size D90 < 50μm: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with D90 < 50μm particle size is used in oral powder formulations, where fine particle size promotes rapid dissolution and improved bioavailability. Moisture Content < 2%: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content below 2% is used in premixed feed supplements, where low moisture content prevents product caking and prolongs shelf life. Stability at 40°C for 6 Months: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability at 40°C for 6 months is used in injectable veterinary medications, where thermal stability guarantees potency during storage and transport. Bulk Density 0.45 g/cm³: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a bulk density of 0.45 g/cm³ is used in capsule manufacturing, where optimal density enhances uniform capsule filling and dosage accuracy. Heavy Metals < 10 ppm: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with heavy metals below 10 ppm is used in oral veterinary granules, where minimized impurities ensure safety for animal consumption. HPLC Content ≥ 98%: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with HPLC content of not less than 98% is used in solution preparations for livestock, where high assay purity assures reliable dosing and clinical outcomes. Melting Point 220°C: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a melting point of 220°C is used in veterinary tablet compression processes, where high melting point withstands manufacturing temperatures without degradation. Solubility in Water > 95%: Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with water solubility greater than 95% is used in veterinary oral solutions, where excellent solubility enables fast and complete absorption. |
Competitive Glycyrrhizae Radix Et Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Walking through the manufacturing floor where Glycyrrhizae Radix Et Rhizoma gets processed never feels quite routine. The root travels from shady, carefully managed fields straight to specialized extraction lines. Our day at the plant starts with the unmistakable earthiness of these roots, spread across large stainless-steel bins for inspection. At this scale, small variations in color or moisture stand out. Consistency begins here. We find that starting with raw roots sourced under strict botanical verification sets a precedent for everything that follows—the qualities of the finished product always reflect the integrity of these first steps.
Glycyrrhizae Radix Et Rhizoma comes straight from licorice root, and our manufacturing runs adhere to veterinary grade quality for active pharmaceutical ingredients (APIs). Animals do not just receive scaled-down copies of human medicine: veterinary APIs face a different set of requirements, shaped by animal digestive systems, feed blendings, and dosing practices. Since 2008, our lines have shifted toward higher-purity extracts with transparent batch records, given the scrutiny that animal health agencies apply to all veterinary medicines. This product’s specifications draw from ongoing collaboration with pharmaceutical partners developing tablets, capsules, injections, powders, granules, solutions, and premixes for livestock and companion animals.
Most demand focuses on two models: the standard veterinary grade and the high-purity refined. Our standard line focuses on delivering a balance between glycyrrhizic acid content and other beneficial components retained from the raw root—target ranges and documentation keep things predictable. The high-purity model strips down extraneous plant matter further, tightening the glycyrrhizic acid percentage and reducing batch-to-batch deviation. Manufacturers of tablets and injectable formulations often prefer this. The way each batch is filtered, standardized, and checked at our plant sets our models apart in the actual handling by pharmaceutical factories—down to how tablets break or how solutions dissolve.
Across veterinary practice, Glycyrrhizae Radix Et Rhizoma brings much more to the table than flavor or tradition, though both matter. Investigations into its pharmacological effects show strong anti-inflammatory action, immune modulation, and support for liver health. Farm veterinarians sometimes describe it as “the helper,” a safe way to support stressed animals during outbreaks or metabolic shifts. People managing large herds reach for premixes containing this API to keep cattle, swine, and poultry robust against routine stresses—transport, weaning, feed transitions. The fact that it works across species, paired with a reassuring safety record, keeps manufacturers like us committed to tight process controls for its veterinary-grade forms.
Tablet makers call for fine, free-flowing powder, since a granule stuck in a press can slow production by hours. Through our own work with tablet lines, we ve found the wet granulation steps respond best to powder with low residual moisture and reliable mesh size. For manufacturers formulating oral solutions, the concern shifts—a powder with high solubility, free from residues that cloud water or cause nozzle blockages, becomes the top priority. Granule-makers take a middle road, driven by mixing tolerance and ability to blend quickly into feeds without clumping or floating off. This product adjusts to fit every processing challenge; on our end, that means running multiple filtration and drying lines, each fine-tuned to suit a particular use, whether that's a quick-dissolving powder for solutions or a robust granule for automatic dispensers.
A large part of our daily work involves standing between laboratory science and real farm practice. Veterinary Grade Glycyrrhizae Radix Et Rhizoma goes beyond “purity.” Every batch arrives with heavy metal and solvent residual analysis, aflatoxin checks, and microbial screenings that match international best practices (from EUR to USDA frameworks). Our production line maps out every necessary parameter—particle size, color, taste, moisture—while keeping the focus firmly on pharmacopeia benchmarks and practical field performance. Feed producers value that they can receive the exact formulation—powder for soluble blends, granules for premix—delivered on a tight lead time, because veterinary emergencies do not wait.
Our veterinary API does not carry some of the residual excipients or “natural” flavoring agents found in food-grade or confectionery-targeted licorice extracts. High-purity veterinary models also avoid unnecessary aroma fractions, focusing purely on pharmacological actives. Contrary to some beliefs, this isn’t just a question of removing sugar. Human-grade extracts may prioritize flavor or skin-contact safety; most animals encounter APIs in feed or water, where taste plays a supporting role and digestive absorption patterns differ. Human vitamin and herbal supplement lines select for mouthfeel and palatability—the needs of animal medicine deviate. Dosing consistency, feed stability, and solubility matter far more to a veterinary operation than flavor profile.
Factory process for this API revolves around two extremes: flexibility and control. Batches run through steam sterilization tanks, sequence of filtration beds, and low-heat dryers needed to protect thermolabile components. Workers take samples before and after each stage, verifying not only active ingredient content but presence (or absence) of agricultural residues. Minor process steps, like the order in which filtration beds are replaced, can affect outcomes. If a manufacturer overlooks drying curve calibration, clumped powder emerges—rendering an entire day s run less valuable to tablet producers. Our teams adjust based on real-world user feedback; for example, veterinary clients report lower dust levels from post-spray granule batches, so we invest in post-processing sieve refinements rather than only chasing analytical numbers.
Reputation in veterinary ingredient supply grows from discipline as much as from clever extraction tricks. Veterinary authorities scrutinize animal medicine with a focus on safety in the food chain as much as direct animal health, since residue monitoring regimes take priority in many export markets. Working through Good Manufacturing Practice certifiers means adapting documentation constantly. In last year s audit period, our quality staff dealt with over a dozen site visits from national and international regulators—these aren’t just paperwork exercises. One missed cleaning record or imprecise pH reading during extraction brings penalties, sometimes delisting. That’s why a product like veterinary Glycyrrhizae Radix Et Rhizoma keeps every analytical certificate connected to the batch that left the plant.
Few outside manufacturing realize the pressure that comes with securing consistent delivery. Poor weather can halve a licorice harvest; root prices may double within a few months. We maintain large buffer stocks in climate-controlled storage, often arranging forward contracts with several planting bases. The veterinary API business cannot operate like the spot-driven world of human herbal supplements: one delayed shipment disconnects dozens of rural supply lines and endangers coverage during disease outbreaks. Our investments in dedicated logistics partners—who prioritize cold-chain and humidity controls—only grew after a memorable shortage season where product lost during ocean transit led to weeks of reprocessing. Each completed order builds trust not only with the purchasing pharmaceutical plant but with veterinarians depending on that end formulation in the field.
Decades working with pharmacists and field veterinarians confirm that Glycyrrhizae Radix Et Rhizoma sits at a rare intersection: low toxicity, broad spectrum support, and compatibility with combination therapies. The main reason for its inclusion comes down to reliability. Whether supporting swine through respiratory stress or ensuring robust digestion during feed changeovers in poultry, the extract’s steady presence allows other medicines—antibiotics, vitamins, antiparasitics—to function with less risk of unwanted reaction. It sees use not just for acute disease events but in routine dietary supplementation, promoting resilience across changing seasons and intensive production cycles. This API keeps showing up in both emergency packs and in the regular feed formulations that reduce costly setbacks for producers.
Veterinary manufacturers find themselves at the center of a sustainability conversation. Glycyrrhizae Radix Et Rhizoma does not rely on synthetic precursor chemicals; its root-based origin means supply must always balance yield with environmental preservation. Our buyers audit harvesters for sustainable agriculture practices, starting far upstream of any extraction tanks. Downstream, animal trials report favorable outcomes, with no evidence of adverse behavioral or systemic effects when included at recommended dosages in feeding rations. We respond to increased calls for transparent, plant-based alternatives to growth-promoting drugs—our product enters those discussions as a proven, low-resistance supplement with a lengthy safety record. We continue to support university and industry research tracking not just clinical endpoints but also long-term welfare indicators.
We conduct batch analysis for every shipment: glycyrrhizic acid content, moisture, ash, mesh size, and verified residue levels. The technical numbers mean less by themselves than what end users see during blending or administration. High moisture readings, even slightly above spec, spell trouble for premix feed blenders—leading to caking or clumping. Granular uniformity influences dosing, where one off-size particle may block metering feeders. Particle size comes into play most for manufacturers designing rapid-dissolving injectables, since even minimally oversized particles disrupt needle passage or settle quickly. On our end, every change in technical specification—be it mesh refinement or moisture control—traces back to direct user feedback. The teams processing this API keep detailed logs and samples, so they can troubleshoot customer complaints and continually refine output.
Demand for Glycyrrhizae Radix Et Rhizoma spans traditional forms like powders and tablets, all the way to capsules, injectables, premixes and granules. We purposely run short production batches for pilot-scale tests with pharmaceutical partners launching new formulations, since these almost always require minor tweaks—altering drying times, adjusting mill settings, or swapping sieves for a finer or coarser end product. The same root extraction can serve as the base for a water-soluble oral solution, a slow-release granule, or a direct-tablet powder—the challenge comes in lining up process controls so the same active ingredient meets very different handling and release requirements. This operational flexibility only comes through experience and regular, sometimes daily, back-and-forth with end users troubleshooting everything from powder bridging to solution clarity in field applications.
Manufacturing feedback channels have stayed vital to the evolution of this veterinary-grade API. Over the past ten years, many changes—like tighter mesh ranges or solvent residue cutoffs—trace back to user field reports. Feed producers flagged issues where powders failed to mix evenly without dusting equipment, prompting the roll-out of a post-granulation spray to cut down airborne fines. Tablet manufacturers highlighted chipping problems that required us to adjust both mixer blade geometry and final moisture targets. Veterinary injection lines requested even further microfiltration, translating into development work on micron-level sieving. Each of these stories starts with a call or visit from pharmaceutical clients handling actual animals. We feed this experience back through the long chain—raw procurement, extraction, drying, granulation, and final packing—so the next round of customers encounters a smoother and more predictable product.
Today’s animal health challenges include more than infectious disease: immune stress, metabolic overload, and the need to reduce antibiotic dependence require new thinking from ingredient manufacturers. We direct significant resources into research partnerships, trialing modified extraction techniques that enhance select bioactive fractions or improve solubility. Newer high-throughput chromatography lines allow us to separate more efficiently, minimizing unwanted flavor notes without sacrificing key pharmacological constituents. Working with outside laboratories and end-user facilities, each process innovation runs through pilot-scale production before finding its way onto the larger lines. This constant pace of improvement reflects not only regulatory pressure but practical field necessity—dairy operators, poultry integrators, and swine producers depend on ingredient reliability during cycles of rapid expansion and contraction.
Modern veterinary supply chains live and die by documentation. Every drum or bag of Glycyrrhizae Radix Et Rhizoma that ships from our plant includes full batch records—sourcing details, process logs, multiple points of certificate-of-analysis, and trace adulterant checks. In the event of any downstream issue, this full stack of records allows customers to track and verify not only ingredient composition but place of origin and processing history. Required audits—both internal and external—also depend on a shared understanding of traceability from root to end-application. We invest in digital recordkeeping, continuous process validation, and staff training so that traceability keeps pace with both regulator and customer expectations. Accountability defines long-term manufacturing relationships in veterinary APIs.
Supplying pharmaceutical companies is only half the job; the rest comes in responsibility for both animal health and downstream food safety. Every farm veterinarian’s feedback, every batch result, feeds back into the systems upstream—this is a cycle that, if managed well, keeps the standards moving up. Producers count on this manufacturing knowledge not as marketing language but as reassurance in daily practice. Our role remains: to deliver Glycyrrhizae Radix Et Rhizoma Veterinary Grade API in a form that fits not abstract specifications but those moments when veterinarians count on it to support animal wellbeing and, by extension, public food safety.